HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Regunera

FDA

Regulatory intelligence
FDAsafety guidance72% confidence

Early Alert: Intravascular Administration Set Issue from Baxter

Source: FDA

Why This Matters

Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Baxter.

Regulatory Analysis

Baxter administration sets may have air bubbles in the drip chamber and tubing, which may result in air being delivered through the IV line to the patient.

Supporting Context

Therapeutic area
Medical Devices · IV Administration
Sub-indication
General

Related signal: Baxter Faces Early Alert Over Intravascular Administration Set Air Bubble Issue

Source

View source document

Related Signal

Open signal — Baxter Faces Early Alert Over Intravascular Administration Set Air Bubble Issue
PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.